×
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
×
Is Trauma a Causal Agent of Psychopathologic Symptoms in Posttraumatic Stress Disorder? Findings From Identical Twins Discordant for Combat Exposure PDF
$ 40.00
Is Trauma a Causal Agent of Psychopathologic Symptoms in Posttraumatic Stress Disorder? Findings From Identical Twins Discordant for Combat Exposure PDF quantity
$ 40.00
×
A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia PDF
$ 40.00
A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia PDF quantity
$ 40.00
×
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan PDF
$ 40.00
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan PDF quantity
$ 40.00
×
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF
$ 40.00
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Open-Label Risperidone for Asperger's Disorder: Negative Symptom Spectrum Response PDF
$ 40.00
Open-Label Risperidone for Asperger's Disorder: Negative Symptom Spectrum Response PDF quantity
$ 40.00
×
Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data PDF
$ 40.00
Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart